This blog explores how key opinion leaders can add value to your clinical investigation and how to balance their influence with practical trial needs.
Blog
Key Opinion Leader Engagement for Your Clinical Investigation
What can KOLs add to your Clinical Investigation?
Key opinion leaders (KOLs) are experts and thought leaders in their field. They are an important resource for R&D, market access and clinical investigations. KOLs can add great value to your clinical investigation by helping you develop a credible study protocol with scientifically relevant outcomes. Prior and during the clinical investigation, A KOL in the role of Principal Investigator can motivate other Investigators and boost enrollment. Their podium presence and influence on peers can be invaluable for dispersing study outcomes and advocating your medical device in the medical community at local, regional or even global levels.
What are risks and limitations when engaging KOLs for clinical investigations?
It is crucial to identify high-performing study sites to make a trial a success. But a good KOL is not necessarily a high enroller. Sponsors focusing only on KOLs as Investigators for their study must be aware that enrollment may not be optimal. It may also be challenging to get all the KOLs to work together efficiently as they often have conflicting or competing interests. In multicenter trials it is therefore essential to engage the right mix of Investigators and to add KOLs selectively. In single center trials the KOL must also have acceptable access to the target patient population, and ideally, he or she can delegate some of the day-to-day study responsibilities to local co-investigators.
How can Qserve help you?
In terms of clinical investigations. Protocol development, site selection and site management are often outsourced to a CRO. Most of the times these activities involve interactions with KOLs. A good CRO will interact with your KOL carefully. They will approach them as a partner and acknowledge the KOL’s time, opinion and scientific expertise, while keeping the study strategy aligned with the Sponsor’s priorities and needs.
At Qserve, we are ready to help you identify the right KOLs for your study and to foster those valuable KOL relationships. Feel free to contact us for additional information.
.png)
Plan your clinical investigation submission in Germany: ensure process clarity and MDR-aligned documents to avoid delays or questions from the EC and BfArM
Discover the differences between a Medical Device/IVD CRO and a Pharma CRO, and why understanding these concepts are essential when choosing a partner.
Global regulations are raising the bar for clinical data in medtech, driving a shift toward more robust pre- and post-market clinical strategies.